Opus Genetics (IRD) Change in Acquisitions & Divestments (2011 - 2020)
Opus Genetics (IRD) reported Change in Acquisitions & Divestments of $3.0 million for Q1 2020, little changed year-over-year from $3.0 million in Q2 2019, and little changed on a QoQ basis from $3.0 million in Q4 2019.
Opus Genetics (IRD) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $3.0 million in Q1 2020.
- Quarterly Change in Acquisitions & Divestments changed 0.0% year-over-year to $3.0 million in Q1 2020, while the trailing twelve-month figure through Sep 2020 was $6.0 million (down 45.45% YoY) and the FY2019 annual result came in at $12.0 million, changed 0.42% from the prior year.
- Change in Acquisitions & Divestments held at $3.0 million in Q1 2020 per IRD's latest filing, from $3.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $5.1 million in Q3 2016 and bottomed at $960000.0 in Q1 2016.
- The 5-year median for Change in Acquisitions & Divestments is $3.0 million (2017), against an average of $3.1 million.
- The widest annual swing landed in 2016, when Change in Acquisitions & Divestments tumbled 80.74%; it then jumped 183.33% in 2017.
- Tracing IRD's Change in Acquisitions & Divestments over 5 years: stood at $4.7 million in 2016, then plunged by 35.9% to $3.0 million in 2017, then sank by 33.33% to $2.0 million in 2018, then jumped by 50.0% to $3.0 million in 2019, then changed by 0.0% to $3.0 million in 2020.
- Per Business Quant, the three latest IRD Change in Acquisitions & Divestments figures stand at $3.0 million (Q1 2020), $3.0 million (Q4 2019), and $3.0 million (Q3 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 3.00 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Dec 31, 2019 | 3.00 Mn |
| Dec 31, 2019 | 3.00 Mn |
| Sep 30, 2019 | 3.00 Mn |
| Sep 30, 2019 | 3.00 Mn |
| Jun 30, 2019 | 3.00 Mn |
| Jun 30, 2019 | 3.00 Mn |
| Mar 31, 2019 | 3.00 Mn |
| Mar 31, 2019 | 3.00 Mn |
| Dec 31, 2018 | 2.00 Mn |
| Dec 31, 2018 | 2.00 Mn |
| Sep 30, 2018 | 3.70 Mn |
| Sep 30, 2018 | 3.70 Mn |
| Jun 30, 2018 | 3.25 Mn |
| Jun 30, 2018 | 3.25 Mn |
| Mar 31, 2018 | 3.00 Mn |
| Mar 31, 2018 | 3.00 Mn |
| Dec 31, 2017 | 3.00 Mn |
| Dec 31, 2017 | 3.00 Mn |
| Sep 30, 2017 | 3.00 Mn |
| Sep 30, 2017 | 3.00 Mn |
| Jun 30, 2017 | 3.00 Mn |
| Jun 30, 2017 | 3.00 Mn |
| Mar 31, 2017 | 2.72 Mn |
| Mar 31, 2017 | 2.72 Mn |
| Dec 31, 2016 | 4.68 Mn |
| Dec 31, 2016 | 4.68 Mn |
| Sep 30, 2016 | 5.12 Mn |
| Sep 30, 2016 | 5.12 Mn |
| Jun 30, 2016 | 2.48 Mn |
| Jun 30, 2016 | 2.48 Mn |
| Mar 31, 2016 | 960,000.00 |
| Mar 31, 2016 | 960,000.00 |
| Dec 31, 2015 | 2.90 Mn |
| Dec 31, 2015 | 2.90 Mn |
| Sep 30, 2015 | 7.00 Mn |
| Sep 30, 2015 | 7.00 Mn |
| Jun 30, 2015 | 2.64 Mn |
| Jun 30, 2015 | 2.64 Mn |
| Mar 31, 2015 | 4.99 Mn |
| Mar 31, 2015 | 4.99 Mn |
| Jun 30, 2012 | 1.85 Mn |
| Jun 30, 2012 | 1.85 Mn |
| Jun 30, 2011 | 8.50 Mn |
| Jun 30, 2011 | 8.50 Mn |